{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:20:06Z","timestamp":1768076406800,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,4,17]],"date-time":"2011-04-17T00:00:00Z","timestamp":1302998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00408-011-9289-0","type":"journal-article","created":{"date-parts":[[2011,4,16]],"date-time":"2011-04-16T07:48:19Z","timestamp":1302940099000},"page":"199-206","source":"Crossref","is-referenced-by-count":33,"title":["Inappropriate Overuse of Inhaled Corticosteroids for COPD Patients: Impact on Health Costs and Health Status"],"prefix":"10.1007","volume":"189","author":[{"given":"Javier","family":"de Miguel-D\u00edez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Carrasco-Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Rejas-Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Mart\u00edn-Centeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gobartt-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valent\u00edn","family":"Hernandez-Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Gil de Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Jimenez-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,17]]},"reference":[{"key":"9289_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1157\/13119943","volume":"44","author":"G Peces-Barba","year":"2008","unstructured":"Peces-Barba G, Barber\u00e0 JA, Agust\u00ed A, Casanova C, Casas A, Izquierdo JL et al (2008) Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT). Arch Bronconeumol 44:271\u2013281 (in Spanish)","journal-title":"Arch Bronconeumol"},{"key":"9289_CR2","unstructured":"World Health Organization (2009) Chronic obstructive respiratory diseases. http:\/\/www.who.int\/mediacentre\/factsheets\/fs315\/en\/index.html . Accessed 7 Jan 2009"},{"key":"9289_CR3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1378\/chest.118.4.981","volume":"118","author":"VS Pe\u00f1a","year":"2000","unstructured":"Pe\u00f1a VS, Miravitlles M, Gabriel R, Jim\u00e9nez-Ruiz CA, Villasante C, Masa JF, Viejo JL, Fern\u00e1ndez-Fau L (2000) Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study. Chest 118:981\u2013989","journal-title":"Chest"},{"key":"9289_CR4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/thx.2009.115725","volume":"64","author":"M Miravitlles","year":"2009","unstructured":"Miravitlles M, Soriano JB, Garcia-Rio F, Mu\u00f1oz L, Duran-Tauleria E, Sanchez G et al (2009) Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64:863\u2013868","journal-title":"Thorax"},{"key":"9289_CR5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","volume":"370","author":"AS Buist","year":"2007","unstructured":"Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM et al (2007) International variation in the prevalence of COPD (The BOLD study): a population-based prevalence study. Lancet 370:741\u2013750","journal-title":"Lancet"},{"key":"9289_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7525-1-18","volume":"1","author":"E Stahl","year":"2003","unstructured":"Stahl E, Jansson SA, Jonsson AC, Svensson K, Lundb\u00e4ck B, Andersson F (2003) Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD. Health Qual Life Outcomes 1:18","journal-title":"Health Qual Life Outcomes"},{"key":"9289_CR7","first-page":"239","volume":"41","author":"J Miguel-D\u00edez de","year":"2005","unstructured":"de Miguel-D\u00edez J (2005) Health care costs of asthma and chronic obstructive pulmonary disease. Arch Bronconeumol 41:239\u2013241 (in Spanish)","journal-title":"Arch Bronconeumol"},{"key":"9289_CR8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1157\/13047332","volume":"39","author":"J Miguel D\u00edez De","year":"2003","unstructured":"De Miguel D\u00edez J, Izquierdo Alonso JL, Rodr\u00edguez Gonz\u00e1lez-Moro JM, De Lucas Ramos P, Molina Par\u00eds J (2003) Drug treatment of chronic obstructive pulmonary disease on two levels of patient care: degree of compliance with recommended protocols. Arch Bronconeumol 39:195\u2013202 (in Spanish)","journal-title":"Arch Bronconeumol"},{"key":"9289_CR9","first-page":"153","volume":"39","author":"J Miguel-Diez de","year":"2002","unstructured":"de Miguel-Diez J, Rodr\u00edguez JL, Calle M, Nieto MA, Alvarez-Sala JL (2002) Chronic obstructive pulmonary disease. Do you comply with the regulations? Med Integral 39:153\u2013160 (in Spanish)","journal-title":"Med Integral"},{"key":"9289_CR10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.rmed.2008.11.019","volume":"103","author":"M Miravitlles","year":"2009","unstructured":"Miravitlles M, Brosa M, Velasco M, Crespo C, Gobartt E, Diaz S et al (2009) An economic analysis of pharmacological treatment of COPD in Spain. Respir Med 103:714\u2013721","journal-title":"Respir Med"},{"key":"9289_CR11","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (2010) Global Strategy for diagnosis, management, and prevention of COPD. Updated 2010. http:\/\/www.goldcopd.org . Accessed 4 April 2011"},{"key":"9289_CR12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","volume":"356","author":"PM Calverley","year":"2007","unstructured":"Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW et al (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775\u2013789","journal-title":"N Engl J Med"},{"key":"9289_CR13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archinternmed.2008.550","volume":"169","author":"S Singh","year":"2009","unstructured":"Singh S, Amin AV, Loke YK (2009) Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med 169:219\u2013229","journal-title":"Arch Intern Med"},{"key":"9289_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1477-7525-4-31","volume":"4","author":"P Carrasco Garrido","year":"2006","unstructured":"Carrasco Garrido P, de Miguel D\u00edez J, Rejas Guti\u00e9rrez J, Mart\u00edn Centeno A, Gobartt V\u00e1zquez E, Gil de Miguel A et al (2006) Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes 4:31","journal-title":"Health Qual Life Outcomes"},{"key":"9289_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0300-2896(01)75074-0","volume":"37","author":"JA Barber\u00e0","year":"2001","unstructured":"Barber\u00e0 JA, Peces-Barba G, Agust\u00ed AG, Izquierdo JL, Mons\u00f3 E, Montemayor T, Viejo JL, Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR) (2001) Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease. Arch Bronconeumol 37:297\u2013316 (in Spanish)","journal-title":"Arch Bronconeumol"},{"key":"9289_CR16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","volume":"106","author":"NR Anthonisen","year":"1987","unstructured":"Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106:196\u2013204","journal-title":"Ann Intern Med"},{"key":"9289_CR17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JE Ware","year":"1996","unstructured":"Ware JE, Kosinski M, Keller SD (1996) A 12-item short-form health survey. Construction of scales and preliminary tests of reliability and validity. Med Care 34:220\u2013233","journal-title":"Med Care"},{"key":"9289_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1157\/13074369","volume":"19","author":"G Vilagut","year":"2005","unstructured":"Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM et al (2005) The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit 19:135\u2013150 (in Spanish)","journal-title":"Gac Sanit"},{"key":"9289_CR19","unstructured":"Spanish National Statistics Institute. Results of 1999. http:\/\/www.ine.es . Accessed December 2003"},{"key":"9289_CR20","first-page":"7","volume":"5","author":"J Miguel D\u00edez de","year":"2007","unstructured":"de Miguel D\u00edez J, Calle Rubio M, Rodr\u00edguez Hermosa JL, \u00c1lvarez-Sala JL (2007) Guidelines for the treatment of COPD. Hot Topics Respir Med 5:7\u201314","journal-title":"Hot Topics Respir Med"},{"key":"9289_CR21","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1378\/chest.117.2_suppl.33S","volume":"117","author":"SD Ramsey","year":"2000","unstructured":"Ramsey SD (2000) Suboptimal medical therapy in COPD. Exploring the causes and consequences. Chest 117:33S\u201337S","journal-title":"Chest"},{"key":"9289_CR22","first-page":"62","volume":"59","author":"M Decramer","year":"2003","unstructured":"Decramer M, Bartsch P, Pauwels R, Yernault JC (2003) Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis 59:62\u201380","journal-title":"Monaldi Arch Chest Dis"},{"key":"9289_CR23","first-page":"662","volume":"56","author":"BM Roede","year":"2006","unstructured":"Roede BM, Bindels PJ, Brouwer HJ, Bresser P, de Borgie CA, Prins JM (2006) Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines. Br J Gen Pract 56:662\u2013665","journal-title":"Br J Gen Pract"},{"key":"9289_CR24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/15412550600829299","volume":"3","author":"T Glaab","year":"2006","unstructured":"Glaab T, Banik NRO, Wencker M (2006) National survey of guideline-compliant COPD management among pneumologists and primary care physicians. COPD 3:141\u2013148","journal-title":"COPD"},{"key":"9289_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ageing\/afi071","volume":"34","author":"CE Ruse","year":"2005","unstructured":"Ruse CE, Molyneux AW (2005) A study of the management of COPD according to established guidelines and the implications for older patients. Age Ageing 34:299\u2013301","journal-title":"Age Ageing"},{"key":"9289_CR26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.rmed.2004.03.018","volume":"98","author":"OT Rutschmann","year":"2004","unstructured":"Rutschmann OT, Janssens JP, Vermeulen B, Sarasin FP (2004) Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med 98:932\u2013937","journal-title":"Respir Med"},{"key":"9289_CR27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2710.2006.00752.x","volume":"31","author":"V Tsagaraki","year":"2007","unstructured":"Tsagaraki V, Markantonis SL, Amfilochiou A (2007) Pharmacotherapeutic management of COPD patients in Greece\u2014adherence to international guidelines. J Clin Pharm Ther 31:369\u2013374","journal-title":"J Clin Pharm Ther"},{"key":"9289_CR28","first-page":"63","volume":"41","author":"J Miguel D\u00edez de","year":"2005","unstructured":"de Miguel D\u00edez J, Izquierdo Alonso JL, Molina Par\u00eds J, Bell\u00f3n Cano JM, Rodr\u00edguez Gonz\u00e1lez-Moro JM, de Lucas Ramos P (2005) [Factors affecting drug prescription in patients with stable COPD: results from a multicenter Spanish study (IDENTEPOC). Arch Bronconeumol 41:63\u201370 (in Spanish)","journal-title":"Arch Bronconeumol"},{"key":"9289_CR29","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.rmed.2007.02.019","volume":"101","author":"M Miravitlles","year":"2007","unstructured":"Miravitlles M, De la Roza C, Naberan K, Lamban M, Gobartt E, Mart\u00edn A (2007) Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med 101:1753\u20131760","journal-title":"Respir Med"},{"key":"9289_CR30","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1378\/chest.112.5.1278","volume":"112","author":"ZM Corden","year":"1997","unstructured":"Corden ZM, Bosley CM, Rees PJ, Cochrane GM (1997) Home nebulized therapy for patients with COPD: patients\u2019 compliance with treatment and its relation to quality of life. Chest 112:1278\u20131282","journal-title":"Chest"},{"key":"9289_CR31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1081\/COPD-120039809","volume":"1","author":"JL Izquierdo Alonso","year":"2004","unstructured":"Izquierdo Alonso JL, De Miguel D\u00edez J (2004) Economic impact of pulmonary drugs on direct costs of stable chronic obstructive pulmonary disease. COPD 1:215\u2013223","journal-title":"COPD"},{"key":"9289_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0300-2896(15)30501-9","volume":"34","author":"JL Marco","year":"1998","unstructured":"Marco JL, Martin Berra JC, Corres IM, Luque DR, Zubillaga GG (1998) Chronic obstructive lung disease in the general population. An epidemiologic study performed in Guipuzcoa. Arch Bronconeumol 34:23\u201327 (in Spanish)","journal-title":"Arch Bronconeumol"},{"key":"9289_CR33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0300-2896(15)31109-1","volume":"30","author":"B Brotons","year":"1994","unstructured":"Brotons B, Perez JA, Sanchez-Toril F, Soriano S, Hernandez J, Belenguer JL (1994) The prevalence of chronic obstructive pulmonary disease and asthma. A cross-sectional study. Arch Bronconeumol 30:149\u2013152 (in Spanish)","journal-title":"Arch Bronconeumol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-011-9289-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-011-9289-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-011-9289-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:37:51Z","timestamp":1559068671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-011-9289-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,17]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["9289"],"URL":"https:\/\/doi.org\/10.1007\/s00408-011-9289-0","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,17]]}}}